Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens

European Journal of Pharmacology

Volumn 296, Issue 2, 1996, Pages 169-172

  Pertwee, Roger G ^a   Joe Adigwe, Gozie ^a   Hawksworth, Gabrielle M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Adenylate cyclase; cAMP; Cannabinoid receptor; Cannabinoid receptor antagonist; SR141716A; Vas deferens, mouse

Indexed keywords

11 HYDROXY 1',1' DIMETHYLHEPTYL DELTA8 TETRAHYDROCANNABINOL; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CYCLIC AMP; FORSKOLIN; RECEPTOR SUBTYPE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; ENANTIOMER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VAS DEFERENS;

EID: 0030071798     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00790-3     Document Type: Article

References (13)

1. Bidaut-Russell, M., W.A. Devane and A.C. Howlett, 1990, Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain, J. Neurochem. 55, 21.
2. Deadwyler, S.A., R.E. Hampson and S.R. Childers, 1995, Functional significance of cannabinoid receptors in brain, in: Cannabinoid Receptors, ed. R.G. Pertwee (Academic Press, London) p. 205.
3. Howlett, A.C., M.R. Johnson, L.S. Melvin and G.M. Milne, 1988, Non-classical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model, Mol. Pharmacol. 33, 297.
4. 9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes, Life Sci. 48, 1133.
5. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265.
6. Mechoulam, R. and E. Fride, 1995, The unpaved road to the endogenous brain cannabinoid ligands, the anandamides, in: Cannabinoid Receptors, ed. R.G. Pertwee (Academic Press, London) p. 233.
7. Pacheco, M., S.R. Childers, R. Arnold, F. Casiano and S.J. Ward, 1991, Aminoalkylindoles: actions on specific G-protein-linked receptors, J. Pharmacol. Exp. Ther. 257, 170.
8. Pacheco, M.A., S.J. Ward and S.R. Childers, 1993, Identification of cannabinoid receptors in cultures of rat cerebellar granule cells, Brain Res. 603, 102.
9. Pertwee, R.G., 1995, Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors: an overview, in: Cannabinoid Receptors, ed. R.G. Pertwee (Academic Press, London) p. 1.
10. Pertwee, R.G. and G. Griffin, 1995, A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens, Eur. J. Pharmacol. 272, 67.
11. Pertwee, R.G., L.A. Stevenson, D.B. Elrick, R. Mechoulam and A.D. Corbett, 1992, Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine, Br. J. Pharmacol. 105, 980.
12. Pertwee, R.G., G. Griffin, J.A.H. Lainton and J.W. Huffman, 1995, Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens, Eur. J. Pharmacol. 284, 241.
13. Rinaldi-Carmona, M., F. Barth, M. Héaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J.C. Brelière and G. Le Fur, 1994, SR141716A, a potent and selective antagonist of the brain cannabinoid receptor, FEBS Lett. 350, 240.